Does CABOZANTINIB S-MALATE Cause Dysgeusia? 777 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 777 reports of Dysgeusia have been filed in association with CABOZANTINIB S-MALATE (CABOMETYX). This represents 2.0% of all adverse event reports for CABOZANTINIB S-MALATE.
777
Reports of Dysgeusia with CABOZANTINIB S-MALATE
2.0%
of all CABOZANTINIB S-MALATE reports
27
Deaths
94
Hospitalizations
How Dangerous Is Dysgeusia From CABOZANTINIB S-MALATE?
Of the 777 reports, 27 (3.5%) resulted in death, 94 (12.1%) required hospitalization, and 2 (0.3%) were considered life-threatening.
Is Dysgeusia Listed in the Official Label?
Yes, Dysgeusia is listed as a known adverse reaction in the official FDA drug label for CABOZANTINIB S-MALATE.
What Other Side Effects Does CABOZANTINIB S-MALATE Cause?
Diarrhoea (8,282)
Fatigue (6,819)
Off label use (5,245)
Nausea (4,341)
Decreased appetite (4,076)
Blood pressure increased (2,939)
Malignant neoplasm progression (2,718)
Palmar-plantar erythrodysaesthesia syndrome (2,706)
Weight decreased (2,657)
Stomatitis (2,560)
What Other Drugs Cause Dysgeusia?
NIRMATRELVIR\RITONAVIR (7,381)
SUNITINIB MALATE (1,226)
SODIUM (1,216)
LENALIDOMIDE (1,180)
LIFITEGRAST (1,067)
CLARITHROMYCIN (717)
VISMODEGIB (706)
ADALIMUMAB (674)
PALBOCICLIB (620)
OMEPRAZOLE (601)
Which CABOZANTINIB S-MALATE Alternatives Have Lower Dysgeusia Risk?
CABOZANTINIB S-MALATE vs CAFFEINE
CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL
CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL-MKNL
CABOZANTINIB S-MALATE vs CALCIFEDIOL
CABOZANTINIB S-MALATE vs CALCIPOTRIENE